Nitrofurantoin Genethics Europe

Nitrofurantoin, the active ingredient in Nitrofurantoin Genethics Europe, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It treats uncomplicated urinary tract infections, including cystitis, by targeting susceptible bacteria in the urinary tract and is indicated for the treatment of acute uncomplicated urinary infections caused by sensitive organisms.

GNH USA supplies Nitrofurantoin Genethics Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality and regulatory standards.

Nitrofurantoin is used to treat bacterial infections of the urinary tract.

- Uncomplicated urinary tract infection: eliminates susceptible bacteria, relieving symptoms such as dysuria and frequency. - Cystitis: resolves bladder infection, reducing inflammation and discomfort. - Acute lower urinary tract infection: provides rapid bacterial clearance, preventing progression.

Nitrofurantoin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset occurring in many patients. - Diarrhea: loose stools that may be transient. - Headache: mild to moderate head pain. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or fibrosis requiring medical attention. - Hepatic injury: elevated liver enzymes or hepatitis. - Hemolytic anemia: especially in patients with G6PD deficiency. - Severe allergic reaction: anaphylaxis or angioedema.

Before prescribing Nitrofurantoin, clinicians should consider several safety factors.

- Renal function: assess creatinine clearance before initiating therapy. - Pregnancy: avoid use unless benefits outweigh potential risks. - G6PD deficiency: contraindicated due to risk of hemolysis. - Elderly patients: monitor for pulmonary toxicity and renal impairment. - Drug interactions: review concomitant medications for absorption or toxicity concerns. - Store below 25°C: keep in the original packaging, protect from moisture.

Nitrofurantoin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Probenecid: can increase nitrofurantoin plasma concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance and drug efficacy. - NSAIDs: potential additive renal toxicity. - Oral contraceptives: possible reduction in contraceptive effectiveness.